Welcome to LookChem.com Sign In|Join Free

CAS

  • or

321371-28-2

Methyl 2-dichloroMethyl-4,5-dihydrothiazole-4-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

321371-28-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 321371-28-2 Structure

  • Basic information

    1. Product Name: Methyl 2-dichloroMethyl-4,5-dihydrothiazole-4-carboxylate
    2. Synonyms: Methyl 2-dichloroMethyl-4,5-dihydrothiazole-4-carboxylate
    3. CAS NO:321371-28-2
    4. Molecular Formula: C6H7Cl2NO2S
    5. Molecular Weight: 228.09628
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 321371-28-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 264.8±40.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.61±0.1 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 0.40±0.40(Predicted)
    10. CAS DataBase Reference: Methyl 2-dichloroMethyl-4,5-dihydrothiazole-4-carboxylate(CAS DataBase Reference)
    11. NIST Chemistry Reference: Methyl 2-dichloroMethyl-4,5-dihydrothiazole-4-carboxylate(321371-28-2)
    12. EPA Substance Registry System: Methyl 2-dichloroMethyl-4,5-dihydrothiazole-4-carboxylate(321371-28-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 321371-28-2(Hazardous Substances Data)

321371-28-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 321371-28-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,1,3,7 and 1 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 321371-28:
(8*3)+(7*2)+(6*1)+(5*3)+(4*7)+(3*1)+(2*2)+(1*8)=102
102 % 10 = 2
So 321371-28-2 is a valid CAS Registry Number.

321371-28-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 2-(dichloromethyl)-4,5-dihydro-1,3-thiazole-4-carboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:321371-28-2 SDS

321371-28-2Relevant articles and documents

Incorporation of heterocycles into the backbone of peptoids to generate diverse peptoid-inspired one bead one compound libraries

Aditya, Animesh,Kodadek, Thomas

scheme or table, p. 164 - 169 (2012/05/19)

Combinatorial libraries of peptoids (oligo-N-substituted glycines) have proven to be useful sources of protein ligands. Each unit of the peptoid oligomer is derived from 2-haloacetic acid and a primary amine. To increase the chemical diversity available in peptoid libraries, we demonstrate here that heterocyclic halomethyl carboxylic acids can be employed as backbone building blocks in the synthesis of peptoid-based oligomers. Optimized conditions are reported that allow the creation of large, high quality combinatorial libraries containing these units.

FARNESOID X RECEPTOR AGONISTS

-

Page/Page column 238, (2009/03/07)

The present invention relates to famesoid X receptors (FXR, NR1H4) FXR is a member of the nuclear receptor class of ligand-activate transcription factors More particularly, the present invention relates to compounds useful as agonists for FXR, pharmaceutical formulations comprising such compounds, and therapeutic use of the same Novel isoxazole compounds are disclosed as part of pharmaceutical compositions for the treatment of a condition mediated by decreased FXR activity, such as obesity, diabetes, cholestatic liver disease, liver fibrosis, and metabolic syndrome

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 321371-28-2